BCL2 and diffuse large B-cell lymphoma: Moreover, three of the four intrinsically venetoclax-resistant DLBCL lines that expressed BCL2 also showed sensitivity to ETC inhibition, suggesting this is a common mechanism of venetoclax resistance in DLBCL.